arrow
返回
L

Louis Fehrenbacher

pennsylvania commonwealth system of higher education (pcshe)

78H指数
216论文数
5.9W被引数
收录论文 58
发表时间
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial来自NRG肿瘤学/NSABP B-42试验的乳腺癌指数和激素受体阳性乳腺癌中延长芳香化酶抑制剂治疗益处的预测
err2024-02-20
err4
errOAAI
errMamounas, Eleftherios P.; Bandos, Hanna; Rastogi, Priya; Zhang, Yi; Treuner, Kai; Lucas, Peter C.; Geyer, Charles E.; Fehrenbacher, Louis; Chia, Stephen K.; Brufsky, Adam M.; Walshe, Janice M.; Soori, Gamini S.; Dakhil, Shaker; Paik, Soonmyung; Swain, Sandra M.; Sgroi, Dennis C.; Schnabel, Catherine A.; Wolmark, Norman
err分享
err收藏
Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer
err2023-05-15
err12
errOAAI
errMamounas, Eleftherios P.; Bandos, Hanna; Rastogi, Priya; Lembersky, Barry C.; Jeong, Jong-Hyeon; Geyer Jr, Charles E.; Fehrenbacher, Louis; Chia, Stephen K.; Brufsky, Adam M.; Walshe, Janice M.; Soori, Gamini S.; Dakhil, Shaker R.; Wade III, James L.; McCarron, Edward C.; Swain, Sandra M.; Wolmark, Norman
err分享
err收藏
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology) (March, 10.1007/s10549-021-06417-y, 2022)
err2022-05-04
err1
errOAAI
errGeyer, Charles E., Jr.; Bandos, Hanna; Rastogi, Priya; Jacobs, Samuel A.; Robidoux, Andre; Fehrenbacher, Louis; Ward, Patrick J.; Polikoff, Jonathan; Brufsky, Adam M.; Provencher, Louise; Paterson, Alexander H. G.; Hamm, John T.; Carolla, Robert L.; Baez-Diaz, Luis; Julian, Thomas B.; Swain, Sandra M.; Mamounas, Eleftherios P.; Wolmark, Norman
err分享
err收藏
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)
err2022-03-01
err4
errOAAI
errGeyer, Charles E., Jr.; Bandos, Hanna; Rastogi, Priya; Jacobs, Samuel A.; Robidoux, Andre; Fehrenbacher, Louis; Ward, Patrick J.; Polikoff, Jonathan; Brufsky, Adam M.; Provencher, Louise; Paterson, Alexander H. G.; Hamm, John T.; Carolla, Robert L.; Baez-Diaz, Luis; Julian, Thomas B.; Swain, Sandra M.; Mamounas, Eleftherios P.; Wolmark, Norman
err分享
err收藏
Assessment of estrogen receptor (ESR1) mRNA expression for prediction of extended aromatase inhibitor benefit in HR-positive breast cancer using NRG Oncology/NSABP B-42
err2022-02-15
err0
PREAI
errMamounas, Eleftherios; Bandos, Hanna; Rastogi, Priya; Crager, Michael R.; Mies, Carolyn; Lucas, Peter C.; Geyer, Charles E., Jr.; Fehrenbacher, Louis; Graham, Mark L.; Chia, Stephen K. L.; Brufsky, Adam M.; Walshe, Janice M.; Soori, Gamini S.; Dakhil, Shaker R.; Paik, Soonmyung; Swain, Sandra M.; Baehner, Frederick L.; Shak, Steven; Wolmark, Norman
err分享
err收藏
Identification of PD-L1+status as a candidate predictive biomarker of response to talazoparib (TALA) in the phase 3 EMBRACA study
err2022-02-15
err0
PREAI
errRugo, Hope S.; Blum, Joanne L.; Laird, A. Douglas; Hurvitz, Sara A.; Ettl, Johannes; Mina, Lida A.; Lee, Kyung-Hun; Goncalves, Anthony; Yerushalmi, Rinat; Im, Young-Hyuck; Martin, Miguel; Fehrenbacher, Louis; Roche, Henri H.; Chen, Ying; Lanzalone, Silvana; Chelliserry, Jijumon; Eiermann, Wolfgang; Litton, Jennifer K.
err分享
err收藏
Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer
err2022-02-03
err1
errOAAI
errGanz, Patricia A.; Bandos, Hanna; Geyer, Charles E.; Robidoux, Andre; Paterson, Alexander H. G.; Polikoff, Jonathan; Baez-Diaz, Luis; Brufsky, Adam M.; Fehrenbacher, Louis; Parsons, Ann W.; Ward, Patrick J.; Provencher, Louise; Hamm, John T.; Stella, Philip J.; Carolla, Robert L.; Margolese, Richard G.; Shibata, Henry R.; Perez, Edith A.; Wolmark, Norman
err分享
err收藏
Preservation of quality of life in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial)在曲妥珠单抗和卡培他滨的基础上加用特卡替尼或安慰剂治疗的人表皮生长因子受体2阳性转移性乳腺癌患者的生活质量保护 (HER2CLIMB试验)
err2021-08-01
err11
errOAAI
errMueller, Volkmar; Wardley, Andrew; Paplomata, Elisavet; Hamilton, Erika; Zelnak, Amelia; Fehrenbacher, Louis; Jakobsen, Erik; Curtit, Elsa; Boyle, Frances; Brix, Eva Harder; Brenner, Andrew; Crouzet, Laurence; Ferrario, Cristiano; Munoz-Mateu, Montserrat; Arkenau, Hendrik-Tobias; Iqbal, Nayyer; Aithal, Sramila; Block, Margaret; Cold, Soeren; Cancel, Mathilde; Hahn, Olwen; Poosarla, Teja; Stringer-Reasor, Erica; Colleoni, Marco; Cameron, David; Curigliano, Giuseppe; Siadak, Muriel; DeBusk, Kendra; Ramos, Jorge; Feng, Wentao; Gelmon, Karen
err分享
err收藏
MAF Amplification and Adjuvant Clodronate Outcomes in Early-Stage Breast Cancer in NSABP B-34 and Potential Impact on Clinical Practice
err2021-05-28
err11
errOAAI
errPaterson, Alexander H. G.; Lucas, Peter C.; Anderson, Stewart J.; Mamounas, Eleftherios P.; Brufsky, Adam; Baez-Diaz, Luis; King, Karen M.; Lad, Thomas; Robidoux, Andre; Finnigan, Melanie; Sampayo, Miguel; Tercero, Juan Carlos; Mairet, Joel Jean; Wolff, Antonio C.; Fehrenbacher, Louis; Wolmark, Norman; Gomis, Roger R.
err分享
err收藏
NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab
err2021-05-20
err10
errOAAI
errGanz, Patricia A.; Cecchini, Reena S.; Fehrenbacher, Louis; Geyer, Charles E., Jr.; Rastogi, Priya; Crown, John P.; Thirlwell, Michael P.; Ellison, David M.; Boileau, Jean-Francois; Flynn, Patrick J.; Jeong, Jong-Hyeon; Mamounas, Eleftherios P.; Wolmark, Norman
err分享
err收藏
Antimullerian Hormone as a Serum Biomarker for Risk of Chemotherapy-Induced Amenorrhea
err2020-11-07
err5
errOAAI
errRuddy, Kathryn J.; Schaid, Daniel J.; Batzler, Anthony; Cecchini, Reena S.; Partridge, Ann H.; Norman, Aaron; Fehrenbacher, Louis; Stewart, Elizabeth A.; Trabuco, Emanuel; Ginsburg, Elizabeth; Couch, Fergus J.; Fasching, Peter A.; Vachon, Celine; Ganz, Patricia A.
err分享
err收藏
Impact of tucatinib on health-related quality of life (HRQoL) in patients with HER2+metastatic breast cancer (MBC) with and without brain metastases (BM)
err2020-09-01
err5
errOAAI
errMueller, V.; Paplomata, E.; Hamilton, E. P.; Zelnak, A.; Fehrenbacher, L.; Jakobsen, E. H.; Curtit, E.; Boyle, F.; Brix, E. H.; Brenner, A. J.; Ferrario, C.; Munoz-Mateu, M.; Arkenau, T.; Gelmon, K. A.; Cameron, D.; Curigliano, G.; DeBusk, K.; Ramos, J.; An, X.; Wardley, A. M.
err分享
err收藏
Ten-year results from NRG Oncology/NSABP B-42: A randomized, double-blinded, placebo-controlled clinical trial of extended adjuvant endocrine therapy with letrozole (L) in postmenopausal women with hormone-receptor plus breast cancer (BC) who have completed previous adjuvant therapy with an aromatase inhibitor (AI)
err2020-02-15
err7
PREAI
errMamounas, Eleftherios P.; Bandos, Hanna; Lembersky, Barry C.; Jeong, Jeon Hyeon; Geyer, Charles E., Jr.; Rastogi, Priya; Fehrenbacher, Louis; Graham, Mark L.; Chia, Stephen K.; Brufsky, Adam M.; Walshe, Janice M.; Soori, Gamini S.; Dakhil, Shaker R.; Seay, Thomas E.; Wade, James L., III; McCarron, Edward C.; Paik, Soonmyung; Swain, Sandra M.; Wickerham, D. Lawerence; Wolmark, Norman
err分享
err收藏
Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence乳腺癌患者的辅助内分泌治疗: 卫生系统外展计划对提高依从性的影响
err2020-01-23
err3
errOAAI
errLee, Catherine; Check, Devon K.; Manace Brenman, Leslie; Kushi, Lawrence H.; Epstein, Mara M.; Neslund-Dudas, Christine; Pawloski, Pamala A.; Achacoso, Ninah; Laurent, Cecile; Fehrenbacher, Louis; Habel, Laurel A.
err分享
err收藏
Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy
err2019-10-21
err23
errOAAI
errRugo, Hope S.; Ettl, Johannes; Hurvitz, Sara A.; Goncalves, Anthony; Lee, Kyung-Hun; Fehrenbacher, Louis; Mina, Lida A.; Diab, Sami; Woodward, Natasha E.; Yerushalmi, Rinat; Goodwin, Annabel; Blum, Joanne L.; Martin, Miguel; Quek, Ruben G. W.; Tudor, Iulia Cristina; Bhattacharyya, Helen; Gauthier, Eric; Litton, Jennifer K.; Eiermann, Wolfgang
err分享
err收藏
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer间质肿瘤浸润淋巴细胞在早期HER2-Positive乳腺癌NRG肿瘤学/NSABP B-31辅助试验中的应用
err2019-03-19
err38
errOAAI
errKim, Rim S.; Song, Nan; Gavin, Patrick G.; Salgado, Roberto; Bandos, Hanna; Kos, Zuzana; Floris, Giuseppe; Van den Eynden, Gert G. G. M.; Badve, Sunil; Demaria, Sandra; Rastogi, Priya; Fehrenbacher, Louis; Mamounas, Eleftherios P.; Swain, Sandra M.; Wickerham, D. Lawrence; Costantino, Joseph P.; Paik, Soonmyung; Wolmark, Norman; Geyer, Charles E., Jr.; Lucas, Peter C.; Pogue-Geile, Katherine L.
err分享
err收藏
METRIC: A randomized international phase 2b study of the antibody-drug conjugate (ADC) glembatumumab vedotin (GV) in gpNMB-overexpressing, metastatic, triple-negative breast cancer (mTNBC)
err2019-02-15
err10
PREAI
errVahdat, L. T.; Forero-Torres, A.; Schmid, P.; Blackwell, K.; Telli, M. L.; Melisko, M.; Holgado, E.; Moebus, V.; Cortes, J.; Fehrenbacher, L.; Montero, A. J.; Ma, C.; Nanda, R.; Wright, G. S.; He, Y.; Bagley, R. G.; Halim, A.; Turner, C. D.; Yardley, D. A.
err分享
err收藏
Long-term survival in patients with advanced non-small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study
err2019-01-01
err86
PREAI
errvon Pawel, J.; Bordoni, R.; Satouchi, M.; Fehrenbacher, L.; Cobo, M.; Han, J. Y.; Hida, T.; Moro-Sibilot, D.; Conkling, P.; Gandara, D. R.; Rittmeyer, A.; Gandhi, M.; Yu, W.; Matheny, C.; Patel, H.; Sandler, A.; Ballinger, M.; Kowanetz, M.; Park, K.
err分享
err收藏
Quality of life with talazoparib versus physician's choice of chemotherapy in patients wits advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA ease III trial
err2018-09-01
err100
errOAAI
errEttl, J.; Quek, R. G. W.; Lee, K. -H.; Rugo, H. S.; Hurvitz, S.; Goncalves, A.; Fehrenbacher, L.; Yerushalmi, R.; Mina, L. A.; Martin, M.; Roche, H.; Im, Y. -H.; Markova, D.; Bhattacharyya, H.; Hannah, A. L.; Eiermann, W.; Blum, J. L.; Litton, J. K.
err分享
err收藏
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA MutationTalazoparib在患有晚期乳腺癌和生殖系BRCA突变的患者中
err2018-08-23
err1.5K
errOAAI
errLitton, Jennifer K.; Rugo, Hope S.; Ettl, Johannes; Hurvitz, Sara A.; Goncalves, Anthony; Lee, Kyung-Hun; Fehrenbacher, Louis; Yerushalmi, Rinat; Mina, Lida A.; Martin, Miguel; Roche, Henri; Im, Young-Hyuck; Quek, Ruben G. W.; Markova, Denka; Tudor, Iulia C.; Hannah, Alison L.; Eiermann, Wolfgang; Blum, Joanne L.
err分享
err收藏